Despite the tremendous market gains since mid-February when I was telling my subscribers to aggressively buy stocks at just the right time, it’s still possible to find interesting stocks with great potential.
A favorite biotech stock I reiterated on a pullback four days ago is already up 8%, in a flat market. This stock is up 220% since I first suggested it on March 31, 2014. (At one point it was up 685%.) The market is up 17%, and biotech stocks are up 28% (IBB).
The “safer” eight names in the Brush Biotech 15 portfolio I launched on January 25, 2016 (the top eight names in the group by size), were up 21.2% as of early June, compared to 5.2% for the IBB biotech ETF.
If you want stocks from the system I used to find these names, come join the hedge fund managers, mutual fund managers, brokers from top five banks, sell side analysts and individual investors who have subscribed to my stock letter Brush Up on Stocks for years.
You can subscribe here.
Want to know more?
To find the best stocks for you, I use the skills I’ve learned over the past two decades at Columbia Business School, Johns Hopkins University, the New York Times, and the Economist Group, among other major business publications.
I look for the right kind of insider buying, cheap relative valuation, smart money ownership, financial strength, good growth potential, and opportune sentiment extremes since I am a contrarian investor. My system has worked well over the years. I suggest about 10-20 new stocks per month.
Importantly, I offer unbiased analysis. I have no conflicts of interest. Many brokers, financial advisers and analysts have hidden agendas. I don’t.
So come join us. To get regular investment and trading insights you’ll find nowhere else, click here.
You may cancel for a full refund on the remaining portion of your subscription, anytime. But that doesn’t normally happen.